
-
2007
Company Description
Oncolix is a clinical-stage bio-pharmaceutical company developing a therapeutic protein for the treatment of cancer.
Oncolix is a clinical-stage biotechnology company that is focused on cancer. The company is currently conducting a Phase I clinical trial for the indication of ovarian cancer. The drug, Prolanta, is a prolactin receptor antagonist. The mechanism of action is autophagocytosis or autophagy.
-
Manufacturer:
Science and Engineering -
Formed:
2007 -
Company Website:
-
Company E-mail:
-
Company Address:
14405 WALTERS ROAD, SUITE 780Houston, TXUnited States -
CEO:
- Michael T. Redman
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits